NCT02500329

Effect of Gemigliptin or Acarbose on Endothelial Function in Type 2 DM Patients

Effect of Gemigliptin or Acarbose on Endothelial Function in Type 2 DM Patients (GetUp Trial)

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 54 (estimated)
• Sponsor: Seoul National University Hospital · Academic / Other
• Sex: All
• Age: 20 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

This is a phase 4, single center, randomized, open-labeled study. The primary objective of the study is to compare effect of gemigliptin and acarbose on endothelial function. Subjects are randomized to gemigliptin or acarbose group and maintained intial treatment for 4 weeks.

Conditions

• Endothelial Function
• Type 2 Diabetes
• Gemigliptin
• Acarbose

Interventions

Type	Name	Description
DRUG	Gemigliptin	Gemigliptin for 4 weeks
DRUG	Acarbose	Acarbose for 4 weeks

Timeline

• Start date: 2014-09-01
• Primary completion: 2015-12-01
• First posted: 2015-07-16
• Last updated: 2015-07-16

Locations

1 site across 1 country: South Korea